Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AngioDynamics ( (ANGO) ) has provided an announcement.
AngioDynamics will host a virtual NanoKnife Irreversible Electroporation Prostate Investor Event, highlighting its FDA-cleared non-thermal radiation-free ablation technology for prostate cancer treatment. The company is dedicated to transforming its product portfolio and improving its financial profile by investing in R&D, clinical data generation, and strategic business development to drive growth in larger, faster-growing markets.
More about AngioDynamics
AngioDynamics is a leading medical technology company focused on developing innovative solutions to enhance patient outcomes and improve quality of life. The company’s strategic focus includes expanding treatment options for cardiovascular disease and cancer, with a portfolio that includes technologies for mechanical thrombectomy and prostate focal therapy.
YTD Price Performance: 4.68%
Average Trading Volume: 532,612
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $376.7M
For an in-depth examination of ANGO stock, go to TipRanks’ Stock Analysis page.